GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM

大急流城临床肿瘤学计划

• 批准号: 7473216
• 负责人: Martin J Bury
• 金额: $ 119.87万
• 依托单位: SPECTRUM HEALTH HOSPITALS
• 依托单位国家: 美国
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-06-01 至 2010-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7473216
• 关键词: Achievement; Adolescent; Applications Grants; Arts; Budgets; Cancer Control; Cancer Control Research; Caring; Catchment Area; Child Care; Clinical Oncology; Clinical Research; Clinical Trials; Commit; Communities; Community Clinical Oncology Program; Computer software; Country; Development; Education; Elderly; Electronics; Enrollment; Equipment and supply inventories; Evaluation; Funding; Future; Goals; Grant; Growth; Health; Healthcare Systems; Hispanics; Hospitals; Individual; Investigational Drugs; Leadership; Malignant Neoplasms; Michigan; Mission; Modality; National Cancer Institute; Numbers; Online Systems; Paper; Patient Schedules; Patients; Persons; Pharmaceutical Preparations; Pharmacists; Pharmacy facility; Physicians; Population; Prevention; Primary Care Physician; Primary Health Care; Program Development; Protocols documentation; Provider; Radiation Therapy Oncology Group; Research; Research Ethics Committees; Research Personnel; Resources; Screening procedure; Site; Specialist; System; Therapeutic; Travel; Underrepresented Minority; Update; Vision; Work; base; cancer care; cancer prevention; cancer therapy; community organizations; cost; cost effectiveness; data management; improved; innovation; medical specialties; novel strategies; oncology; programs; software systems; treatment trial; young adult

DESCRIPTION (provided by applicant): The Grand Rapids Clinical Oncology Program (GRCOP) has achieved a national reputation for excellence in community cancer care through its 29-year participation in programs of the National Cancer Institute. In 2003, the GRCOP was highlighted by the NCI as one of 27 CCOPs continuously funded since 1983. The GRCOP comprises a consortium of nine health care systems/hospitals in Western and lower-Northern Michigan and seeks to continue to meet the community's need for innovative and relevant studies of promising therapeutic modalities and cancer controls research. The ongoing mission of the Grand Rapids Clinical Oncology Program is to assure that every person in the region served is provided an opportunity for participation in national cancer prevention and treatment clinical trials. Additionally, we strive to provide education about cancer and the NCI clinical trials program. This grant application encompasses and articulates an ever-expanding vision for the GRCOP. Key strategies to increase patient access and accrual to research protocols include: (1) expansion of on-site screening and patient identification for enrollment in research protocols; (2) development of a targeted clinical trials program for adolescents/young adults; (3) the addition of the Radiation Oncology Therapy Group (RTOG) as a research base, bringing the number of NCI research bases with which the GRCOP affiliates to 8; (4) partnering with NCI in its efforts to increase accrual of the elderly population to clinical trials; and (5) increased involvement by primary care providers and specialty physicians in cancer prevention and control protocols. Strategic initiatives to increase access to and participation in cancer clinical trials by underserved and minority populations incorporate alignment with community organizations throughout the patient catchment area, with an expanding focus on the growing Hispanic/Latino population. Of importance during this upcoming grant cycle will be the GRCOP's continued focus on improving the efficiency and cost-effectiveness of participation in clinical trials through expansion of its data management software system to include both a drug inventory management module and an IRB module. The GRCOP is confident these goals will be accomplished because of the investigators and staff firmly believes that what they do is critically important for present and future oncologic care. The Grand Rapids Clinical Oncology Program represents a proven resource with significant ongoing potential to serve the objectives of the National Cancer Institute's CCOP program. Convinced that our patients are better served by the availability of a strong, quality-oriented community research program, the Grand Rapids Clinical Oncology Program is committed to remaining one of the most successful CCOPs in the country, contributing significantly to oncology clinical research.

描述（由申请人提供）： Grand Rapids临床肿瘤学计划（GRCOP）通过与国家癌症研究所计划的29年参与，在社区癌症护理方面取得了卓越的卓越声誉。 2003年，NCI强调了GRCOP，这是自1983年以来不断资助的27个CCOP之一。该GRCOP由密歇根州西部和下北部的九个医疗保健系统/医院组成，并试图继续满足社区对有效的治疗方法和癌症控制和癌症控制的创新和相关研究的需求。大急流城临床肿瘤学计划的持续任务是确保该地区所服务的每个人都有机会参加国家癌症预防和治疗临床试验。此外，我们努力提供有关癌症和NCI临床试验计划的教育。该赠款应用程序包括对GRCOP的不断扩展的愿景。提高患者访问和研究方案的关键策略包括：（1）扩展现场筛查和患者识别研究方案的注册； （2）为青少年/年轻人制定有针对性的临床试验计划； （3）将辐射肿瘤学治疗组（RTOG）添加为研究基础，使GRCOP分支机构的NCI研究基础数量达到8； （4）与NCI合作，努力将老年人群的应计为临床试验； （5）初级保健提供者和专科医生参与癌症预防和控制方案的参与。服务不足和少数群体的战略举措涵盖了与整个患者集水区的社区组织的一致性，并通过不断增长的西班牙裔/拉丁裔人口进行了扩展。在即将到来的赠款周期中的重要性将是GRCOP继续专注于通过扩展其数据管理软件系统来提高参与临​​床试验的效率和成本效益，以包括药物库存管理模块和IRB模块。由于调查人员和员工坚信，他们所做的事情对于当前和未来的肿瘤护理至关重要，因此GRCOP相信这些目标将得到实现。 Grand Rapids临床肿瘤学计划代表了一种可靠的资源，具有为国家癌症研究所CCOP计划提供目标的巨大潜力。大急流城临床肿瘤学计划确信，通过强大，质量的社区研究计划的可用性为我们的患者提供了更好的服务。